MedTrace Logo

Effect of Sunlight Exposure on Vitamin D Levels in Children With Cerebral Palsy

NCT07757477 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-08-11

No results posted yet for this study

Summary

The goal of this clinical trial is to learn the effect of sunlight exposure on serum vitamin D levels in children aged 1-5 years with cerebral palsy. This study also aims to assess the effect of sunlight exposure on the incidence of acute respiratory tract infections (ARTIs) and to evaluate the safety of the intervention.

The main questions it aims to answer are:

* Does sunlight exposure increase vitamin D levels in children with cerebral palsy?
* Does sunlight exposure influence the incidence of acute respiratory tract infections in children with cerebral palsy?
* Does sunlight exposure cause acute adverse effects in children with cerebral palsy?

Participants will:

* Randomly assigned to either the sunlight exposure group or the control group.
* Undergo baseline assessments, including vitamin D levels measurement, anthropometric measurements, dietary assessment, and Fitzpatrick skin phototype assessment before randomization.
* Receive sunlight exposure for 10 minutes, three times per week between 11:00 AM to 1:00 PM for 8 weeks (intervention group), while participants in the control group will continue their usual sunlight exposure habits.
* Have caregivers record daily sunlight exposure (intervention group), acute respiratory tract infection episodes, adverse events, and dietary intake during the study period.
* Undergo repeat vitamin D levels measurement and evaluation of dietary intake, ARTI incidence, and adverse events at the end of the 8-week intervention.

Conditions

  • Cerebral Palsy

Interventions

BEHAVIORAL

Sunlight Exposure

Participants will receive sunlight exposure for 10 minutes, three times per week between 11:00 AM-1:00 PM WIB for 8 weeks, with approximately 30% of body surface area exposed.

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Hasriza Eka Putra, dr, Sp.A · Department of Child Health, Faculty of Medicine, University of Indonesia - Cipto Mangunkusumo Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07757477 on ClinicalTrials.gov